Table 1.
Main patient characteristics
| Characteristics | Number of patients (%) |
|---|---|
|
Median age (59 years) |
|
| -Age between 18–59 years |
55 (51) |
| -Age > 59 years |
53 (49) |
|
Performance status (PS Ecog) |
|
| -0 |
80 (74) |
| -1 |
25 (23) |
| -2 |
3 (3) |
|
Stage at diagnosis (n) |
|
| -Stage I |
22 (20) |
| -Stage II |
6 (5) |
| -Stage III |
49 (45) |
| -Stage IV |
31 (29) |
|
Grading |
|
| -G1 |
11 (10) |
| -G2 |
26 (24) |
| -G3 |
71 (66) |
|
Median value of CA 125 |
|
| CA 125 ≥ 205 |
46 (42) |
| Ca 125 < 205 |
43 (40) |
|
D-dimer |
|
| -Hig D-dimer value |
17 (16) |
| -Low D-dimer value |
15 (14) |
|
Comorbidity |
|
| -No comorbidity |
31 (29) |
| -Grade 1 comorbity |
10 (9) |
| -Grade 2 Comorbidity |
67 62) |
|
Adjuvant treatment |
|
| -yes |
17 (16) |
| -no |
10 (9) |
|
First line treatment |
|
| -yes |
64 (59) |
| -no |
2 (2) |
| Neoadjuvant treatment | 15 (14) |